Embolization device and method of manufacturing the same

The three-dimensional unconstrained structure design of the slender and flat component solves the stability and safety issues of the embolization device within the aneurysm, ensuring stable deployment on the inner wall of the aneurysm, and is suitable for the treatment of small-diameter sites such as neurovascular aneurysms.

CN114732470BActive Publication Date: 2024-11-08STRYKER CORP +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202210534926.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2015-12-30
Filing Date
2016-12-28
Publication Date
2024-11-08
Estimated Expiration
2036-12-28

Smart Images

  • Figure CN114732470B_ABST
    Figure CN114732470B_ABST
Patent Text Reader

Abstract

The present invention relates to an embolic device and a method for manufacturing the same. The present invention specifically discloses a flat embolic braid (10) having a first side including a first side surface (14) and a second side including a second side surface (16) facing in a direction opposite to the first side surface, the braid having an elongated constrained structure for deployment through a delivery catheter, and a three-dimensional unconstrained structure, wherein in the three-dimensional unconstrained structure, the braid presents a plurality of continuous loops (12), wherein the braid is at least partially twisted between the plurality of continuous loops so that the first side surface faces the outside of each loop and the second side surface faces the inside of each loop, respectively, regardless of changes in the direction and / or orientation of the braid.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of Chinese patent application No. 201680074865.X, entitled “Embolization device and manufacturing method thereof”, filed on December 28, 2016. Technical Field

[0002] The invention disclosed herein relates to embolic devices. More particularly, the present disclosure relates to methods of making embolic devices. Background Art

[0003] Medical devices such as coils, tubular mesh elements and other expandable elements, hereinafter collectively referred to as "embolic devices", are commonly used to treat various types of vascular defects, particularly aneurysms. An aneurysm is a localized, blood-filled dilation of a blood vessel caused by disease, blood flow / pressure applied in the blood vessel and / or weakening of the blood vessel wall. An aneurysm typically presents a sac-like or balloon-like structure extending from a blood vessel. Aneurysms may rupture and cause hemorrhage, stroke (e.g., intracranial aneurysms) and other consequences that damage the patient. During the treatment of an aneurysm, the embolic device is loaded onto a delivery system in a collapsed or radially compressed delivery structure and then introduced into the aneurysm sac. Once delivered into the aneurysm sac, the embolic device can expand or expand into an expanded structure that fills and occludes the aneurysm. The embolic device can have a variety of sizes and shapes; however, the embolic device used to treat an aneurysm typically presents a spherical secondary structure when deployed in the aneurysm sac. When implanted in the sac, the embolic device can further reinforce the inner wall of the aneurysm sac while blocking the aneurysm, reducing the possibility of aneurysm rupture or preventing further rupture of the aneurysm.

[0004] Embolic devices are typically constructed of self-expanding materials such that when the device is deployed from a delivery system to a target location in a patient, the unconstrained device expands without any assistance. Self-expanding embolic devices may be biased so as to expand when released from a delivery catheter, and / or include shape memory components that allow the device to expand when exposed to predetermined conditions. Some embolic devices may be characterized as hybrid devices having certain properties of self-expanding materials and non-self-expanding materials.

[0005] Embolic devices can be made of various materials, including polymers (e.g., non-bioerodible and bioerodible plastics) and metals. Bioerodible polymer embolic devices are desirable for certain applications due to their biodegradability and the flexibility that is usually increased compared to metal embolic devices. Embolic devices can be made of shape memory or superelastic materials, such as shape memory metals (e.g., shape memory nitinol) and polymers (e.g., polyurethane). This shape memory embolic device can be induced (e.g., by temperature, electric or magnetic fields or light) after being delivered to the treatment site and presents a shape (e.g., a radially expanded shape). Superelastic embolic materials, such as superelastic nitinol, can present a shape after delivery without the need for inductive stimulation. Other device materials include stainless steel, platinum and Elgiloy non-magnetic alloys (Elgiloy). In drug delivery embolic devices, the device can carry and / or the surface of the device can be coated with a bioactive agent or therapeutic agent (e.g., a thrombosis inducing agent).

[0006] A commonly used embolic device is a helical coil, which has a winding wire sized to engage the aneurysm wall. Nevertheless, the embolic coil may migrate out of the aneurysm sac, particularly when delivered to a wider neck aneurysm.

[0007] For example, some exemplary embolic coils are described in U.S. Pat. No. 4,994,069, which discloses an embolic coil that exhibits a linear helical structure when stretched and a folded coiled structure when relaxed. The stretched structure is used to place the coil at the target location (through which the delivery catheter is passed), and once the device is deployed at the target site, the coil exhibits a coiled relaxed structure. The '069 patent discloses various secondary shapes of the embolic coil when deployed at the target site, such as a "flower" shape, a double vortex, and a random coiled shape. Other three-dimensional embolic coils have been described in U.S. Pat. Nos. 5,624,461 (i.e., a three-dimensional filled embolic coil), 5,639,277 (i.e., an embolic coil with a twisted helical shape), and 5,649,949 (i.e., a conical embolic coil of variable cross-section). Embolic coils with little or no inherent secondary shape have also been described, such as in U.S. Pat. Nos. 5,690,666 and 5,826,587.

[0008] Spherical embolic devices are described in U.S. Pat. No. 5,645,558, which discloses that when deployed in an aneurysm, one or more strands may be coiled to form a substantially hollow spherical or ovoid shape including overlapping strands. Other embolic devices that assume a spherical shape when deployed are described in U.S. Pat. No. 8,998,947, which discloses a tubular mesh having petaloid portions that, when deployed in an aneurysm, assume a substantially spherical shape having overlapping petaloid portions.

[0009] Various delivery assemblies for embolic devices are known, for example, Guglielmi's U.S. Pat. Nos. 5,250,071 (i.e., interlocking clasp), 5,312,415 (i.e., interconnected guidewires for delivery of multiple coils), and 5,354,295 and 6,425,893 (i.e., electrolytic detachment). Summary of the invention

[0010] In an exemplary embodiment of the disclosed invention, an embolic device is formed by an elongated flat member having a longitudinal axis, a first side including a first side surface, and a second side including a second side surface, the first and second side surfaces being opposite to each other, and the first side surface and the second side surface facing in opposite directions. The elongated flat member has an elongated constrained structure for deployment to a target vascular site through a delivery catheter and a three-dimensional unconstrained structure, wherein in the three-dimensional unconstrained structure, the elongated flat member presents a plurality of continuous loops, wherein the elongated flat member is twisted at least partially around its longitudinal axis between each of the plurality of loops, such that the first side surface faces the outside of each loop and the second side surface faces the inside of each loop regardless of changes in the direction and / or orientation of the elongated flat member.

[0011] Without limitation, the elongated flat member may be a braid formed by one or more braided members, wherein the one or more braided members are metal wires or metal threads. For example, the elongated flat member may be a flattened tubular braid or a single-layer flat ribbon braid.

[0012] In an exemplary embodiment, the elongated flat member is given a three-dimensional unconstrained structure by heat treating the elongated flat member while the elongated flat member is wound in alternating directions around corresponding posts extending outward from a core shaft, thereby forming a plurality of continuous loops. In a preferred embodiment, the plurality of continuous loops includes at least a first loop defining a first plane, a second loop defining a second plane that is not coplanar with the first plane, and a third loop defining a third plane that is not coplanar with the first or second planes. In an exemplary embodiment, the plurality of continuous loops includes at least five continuous loops.

[0013] In a more specific exemplary embodiment, an embolic device for occluding an aneurysm is provided, the embolic device comprising an elongated flat braid formed of one or more metal braided wires or threads, and having a longitudinal axis, a first side comprising a first side surface, and a second side comprising a second side surface, the first side and the second side being opposite to each other, and the first side surface and the second side surface facing in opposite directions. The elongated flat braid has an elongated constrained structure for deployment into an aneurysm through a delivery catheter, and a three-dimensional unconstrained structure after deployment from the delivery catheter into the aneurysm, wherein in the three-dimensional unconstrained structure, the elongated flat braid presents a plurality of continuous loops, wherein the elongated flat braid is at least partially twisted around its longitudinal axis between each of the plurality of loops, so that the first side surface faces the outside of each loop toward the inner wall of the aneurysm, and the second side surface faces the inside of each loop, respectively, regardless of changes in the direction and / or orientation of the elongated flat braid.

[0014] By way of example, the elongated flat braid may be a flattened tubular braid or a single layer of ribbon braid, wherein the elongated flat braid is imparted with a three-dimensional unconstrained structure by heat treating the elongated flat braid while wrapping the elongated flat braid in alternating directions around respective posts extending outwardly from a core shaft thereby forming a plurality of continuous loops. The plurality of continuous loops preferably comprises at least three continuous loops, including a first loop defining a first plane, a second loop defining a second plane that is not coplanar with the first plane, and a third loop defining a third plane that is not coplanar with the first or second planes. In one embodiment, the plurality of continuous loops comprises at least five continuous loops.

[0015] Other and further aspects and features of the embodiments will become apparent from the ensuing detailed description in view of the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 is a perspective view of an embolic device made in accordance with an embodiment of the disclosed invention;

[0017] Figure 2A-2B According to an embodiment of the disclosed invention, Figure 1 Cross-sectional view of the delivery and deployment structure of the embolic device at the target location.

[0018] Figure 3A-3B According to an embodiment of the disclosed invention, for manufacturing Figure 1 A perspective view and a cross-sectional view of an elongated flat member of an embolic device;

[0019] Figure 4A-4B According to an embodiment of the disclosed invention, Figure 3A A cross-sectional view of an elongated flat member;

[0020] Figure 5A-5Cis a side view of an elongated flat member according to other embodiments of the disclosed invention;

[0021] Figure 6A-6C According to an embodiment of the disclosed invention, Figure 5B A side view of an end portion of an embodiment of the present invention;

[0022] Figure 7A-7B is a perspective view of an elongated flat member according to another embodiment of the disclosed invention;

[0023] Figure 8A-B is a perspective view of an elongated flat member according to yet another embodiment of the disclosed invention;

[0024] Fig. 9 According to the disclosed embodiment of the invention, in the manufacture of Figure 1 The mandrel of the embolization device Figure 3A A perspective view of an elongated flat member;

[0025] Fig.10 According to an embodiment of the disclosed invention, for manufacturing Figure 1 Another mandrel of the embolization device Figure 3A A perspective view of an elongated flat member;

[0026] Fig.11 is based on Fig. 9 and Fig.10 A partially twisted perspective view of an elongated flat member of an embodiment of the invention;

[0027] Fig.12 is a perspective view of a twist of an elongated flat member for illustrative purposes; and

[0028] Fig.13 According to the disclosed embodiment of the invention, manufacturing Figure 1 Schematic representation of the embolization device approach. DETAILED DESCRIPTION

[0029] For the following defined terms, these definitions shall apply unless a different definition is given elsewhere in this specification.

[0030] In this document, whether or not explicitly stated, all numerical values ​​are assumed to be modified by the term "about". The term "about" generally refers to a numerical range that one skilled in the art would consider equivalent to the recited value (i.e., having the same function or result). In many cases, the term "about" can include numbers rounded to the nearest significant figure.

[0031] The recitation of numerical ranges by endpoints includes all numbers within that range (eg, 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).

[0032] As used in this specification, the singular forms "a", "an" and "the" include plural referents unless the context clearly dictates otherwise. As used in this specification, the term "or" is generally used in its sense including "and / or" unless the context clearly dictates otherwise.

[0033] Various embodiments are described below with reference to the accompanying drawings. The drawings are not necessarily drawn to scale, and for clarity, the relative proportions of selected elements may be enlarged, and elements of similar structure or function are represented by the same reference numerals throughout the drawings. It should also be understood that the drawings are intended only to facilitate the description of the embodiments and are not intended to serve as a detailed description of the invention or as a limitation on the scope of the invention which is limited only by the attached claims and their equivalents. In addition, the illustrated embodiments do not need to have all the aspects or advantages shown. Even if not so stated, the aspects or advantages described in conjunction with the specific embodiments are not necessarily limited to the embodiments and may be practiced in any other embodiments.

[0034] Figure 1 An embolic device 10 according to an embodiment of the disclosed invention is shown. The embolic device 10 includes an elongated constraining structure ( 10 ) for deployment to a targeted vascular site 20 (eg, an aneurysm sac) via a delivery catheter 80. Figure 2A The embolic device 10 further comprises a three-dimensional unconstrained structure ( Figure 1 and Figure 2B ), wherein the device 10 presents a plurality of continuous rings 12. For example, the device three-dimensional unconstrained structure is presented after the device 10 is extended from the distal opening 82 of the delivery catheter 80, and / or the delivery catheter 80 is withdrawn proximally relative to the embolic device 10 (or some of each) into the targeted vascular site 20 ( Figure 2B The three-dimensional unconstrained structure is set by applying a series of manufacturing steps to the elongated flat member 100 to include continuous rings 12, wherein the elongated flat member 100 is twisted at least partially around its longitudinal axis between each of the plurality of rings so that regardless of changes in the direction and / or orientation of the elongated flat member 100, the first side surface 14 faces the outside of each ring 12 toward the inner wall 22 of the aneurysm 20, and the second side surface 16 faces the inside 11 of each ring 12 ( Figure 1 , Figure 2B The plurality of continuous rings 12 may include a first ring defining a first plane, a second ring defining a second plane that is not coplanar with the first plane, and a third ring defining a third plane that is not coplanar with the first plane or the second plane. Figure 1 and Figure 2B In some embodiments, the plurality of continuous rings includes at least five continuous rings 12, such as Figure 2B shown.

[0035] The use of a series of manufacturing steps for the elongated flat member 100 to define the three-dimensional unconstrained structure of the occluding device 10 will be described in further detail below.

[0036] like Figure 3A As shown in FIG. 1 , the elongated flat member 100 forming the embolic device 10 has a proximal portion 140, a middle portion 130 and a distal portion 120. The proximal portion 140 includes a proximal end 142, and the distal portion 120 includes a distal end 122. The elongated flat member 100 includes a ribbon-like structure having a rectangular cross-section, such as Figure 3A and Figure 3B Alternatively, the elongated flat member 100 may have any other suitable cross-section, for example, an oval or elliptical shape ( Figure 4A ), flat with rounded edges ( Figure 4B ), flattened tubular ( Figure 7B ) cross-section, etc., or a combination thereof. The elongated flat member 100 further includes a longitudinal axis 13, a first side 4 including a first side surface 14, and a second side 6 including a second side surface 16, the first side 4 and the second side 6 are opposite to each other, and the first side surface 14 and the second side surface 16 face in opposite directions, such as Figure 3A shown.

[0037] For ease of illustration, Figure 3A-3B The elongated flat member 100 shown in FIG. 1 is composed of a single layer 40 of material having a ribbon-like structure. The single layer 40 of material may be porous and / or permeable, for example, a layer 40 ( Figure 5A ), Net 55( Figure 5B ), and / or a layer 40 of material having perforations 57 ( Figure 5C ), etc., or a combination thereof. The wires 50 and / or filaments 50' are made of biocompatible metal and / or polymer materials, alloys, or a combination thereof. For example, one or more wires 50 may have a platinum core with respective outer layers of nitinol. In some embodiments, the elongated flat member 100 comprises a single layer of flat ribbon braid. When the elongated flat member 100 is braided, woven, or meshed, the proximal end 142 and / or the distal end 122 may be fixed, and the multiple wires 50 are attached or connected to each other or another element (e.g., a cap, a non-destructive tip, etc.) at their respective proximal ends 142 and / or distal ends 122 by adhesives, clamps, etc., such as Fig. 6A Alternatively, the proximal end 142 and / or the distal end 122 of the elongated flat member 100 may be unfixed, leaving the plurality of wires 50 loose and free at their respective proximal ends 142 and / or distal ends 122, such as Figure 6B In addition, the coil 123 can be connected to the fixed proximal end 142 and / or the distal end 122 of the elongated flat member 100, such as Figure 6C10. When the embolic device 10 is in a three-dimensional unconstrained configuration, the coil 123 can be made of a shape memory material and can be in an annular structure, such as the ring 12 of the embolic device 10. The coil 123, when disposed at the distal end 122 of the elongated flat member 100, is configured to guide the embolic device when deployed within the aneurysm 20.

[0038] In some embodiments, the elongated flat member 100 comprises a braid formed of one or more braided components, and the one or more braided components are wires or threads.

[0039] In further embodiments, the single layer 40 of material may be a non-porous or impermeable layer of material (eg, solid), such as Figure 3A It should be understood that the single layer 40 of the elongated flat member 100 may include one or more materials, combinations thereof, or alloys thereof.

[0040] In other embodiments, the elongated flat member 100 may be formed from multiple layers 42 (e.g., Fig. 7A ); As described above, these layers can be porous / permeable, non-porous / impermeable and / or include one or more materials, or a combination thereof. The elongated flat member 100 composed of multiple layers 42 can have Figure 3A As a non-limiting example, the elongated flat member 100 may include a tubular member 150, such as Fig. 7A As shown, the tubular member 150 may include a flattened braid or mesh to form Figure 3A Similar flat ribbon structures, such as flat tubular braids, such as Figure 7B The tubular member 150 comprises at least two layers 42 when flattened into a ribbon-like structure, as shown in FIG. Figure 7B In another exemplary embodiment, the elongated flat member 100 may be formed of a cylindrical member 160, such as Fig. 8A As shown, it is flattened to form Figure 3A Similar flat ribbon structures, such as Figure 8B The cylindrical component 160 may be made of one or more materials or a combination thereof. Figure 8A-B The cylindrical member 160 may further include a core 162 and an outer layer 164. As a non-limiting example, the core 162 may be composed of platinum and the outer layer 164 may be composed of nitinol.

[0041] It should be understood that the elongated flat member 100 can be braided by wire, cut by tube, or cut by sheet using a variety of techniques, including laser cutting or etching a pattern onto a tube or sheet, or other suitable techniques. It should be further understood that other suitable structures of the elongated flat member 100 can be considered for manufacturing the embolic device 10.

[0042] Return to reference Figure 3A , the elongated flat member 100 includes a length L1 in the range of about 2 to 40 centimeters, and in some embodiments, L1 ranges from about 5 to 25 centimeters. The elongated flat member 100 further includes a width W1 in the range of about 0.5 to 10 millimeters, and in some embodiments, W1 ranges from about 1 to 3 millimeters. In addition, the elongated flat member 100 includes a thickness T1 in the range of about 0.05 to 0.75 millimeters, and in some embodiments, T1 ranges from about 0.1 to 0.4 millimeters. In some embodiments, one or more dimensions (L1, W1, or T1) of the elongated flat member 100 remain constant throughout the member 100, such that the same dimensions are present from the proximal portion 140 to the distal portion 120. In other embodiments, one or more dimensions (L1, W1, or T1) of the elongated flat member 100 may vary, having different dimensions along the length of the elongated flat member 100 (e.g., a tapered structure).

[0043] The elongated flat member 100 can be made of any number of biocompatible, compressible, elastic materials or combinations thereof, including polymeric materials, metals and metal alloys, such as stainless steel, tantalum or nickel titanium alloys, such as the superelastic nickel titanium alloy known as Nitinol. Certain superelastic alloys may be desirable due to their shape recoverability properties, which allow significant bending without deformation even when used in small-sized elongated flat members 100. In addition, when the embolic device 10 includes an elongated flat member 100 made of a self-expanding material, the unconstrained embolic device 10 is biased to expand into a predetermined deployment structure, which will be described in further detail below. Some superelastic alloys include nickel / titanium alloys (48-58 atomic % nickel and optionally containing an appropriate amount of iron); copper / zinc alloys (38-42 weight % zinc); copper / zinc alloys containing 1- to 10 weight % beryllium, silicon, tin, aluminum or gallium; or nickel / aluminum alloys (36- to 38 atomic % aluminum).

[0044] The elongated flat member 100 may include a radiopaque marker or a layer coated with a radiopaque material. In addition, the elongated flat member 100 may carry and / or the surface of the elongated flat member 100 may be coated with a bioactive agent or therapeutic agent (eg, a thrombosis inducing agent).

[0045] Other suitable metals and alloys for the elongated flat member 100 include platinum group metals, such as platinum, rhodium, palladium, rhenium, and tungsten, gold, silver, tantalum and alloys of these metals, such as platinum / tungsten alloys, etc. or combinations thereof. These metals have significant radiopacity and can be tailored to achieve a suitable blend of flexibility and rigidity in their alloys.

[0046] Fig. 9A schematic diagram of an embodiment of the disclosed invention comprising an elongated flat member 100 and manufactured using a mandrel 200 is shown. Figure 1 The embolic device 10 of the present invention. The elongated flat member 100 is arranged on the mandrel 200. The mandrel 200 includes a handle 210 extending from a proximal portion 240 to a distal portion 220. The distal portion 220 of the mandrel 200 includes a plurality of extension columns 230, 232, 233, 234, 236 and 238. The handle 210 and the transverse extension columns 230, 232, 233, 234, 236 and 238 include cylindrical or tubular structures with circular cross-sections. Alternatively, the handle 210 and the transverse extension columns 230, 232, 233, 234, 236 and 238 may include any other suitable structure, such as, for example, having an elliptical cross-section. Extension posts 230, 232, 233, 234, 236 and 238 extend outwardly from the distal end portion 220 of the handle 210 and are disposed around the distal end portion 220 of the handle 210. Each extension post 230, 232, 233, 234, 236 and 238 includes a respective center point (e.g., 238'), wherein each extension post is disposed at a suitable angle (e.g., about 65 to 95 degrees) relative to the center point of an adjacent post, such as Fig. 9 In an alternative embodiment, the mandrel 200 may include four extension posts, wherein each extension post is disposed at approximately 90 degrees relative to a center point (not shown) of an adjacent post. It should be understood that the mandrel 200 may include any number of extension posts, any number of angles between the extension posts (e.g., the posts may be disposed symmetrically or asymmetrically relative to each other), or any other suitable structure for manufacturing the embolic device 10, such as, for example Fig.10 The mandrel is 200'. Fig.10 The mandrel 200 ′ includes a flat base 240 and a plurality of extension posts 250 , 251 , 252 , 253 , 254 , 255 and 256 extending outwardly from the base 240 .

[0047] The elongated flat member 100 is disposed on the mandrel 200 by placing the elongated flat member 100, specifically either the first side surface 14 or the second side surface 16, against the mandrel 200. For example, when the first side surface 14 of the elongated flat member 100 is disposed against, disposed on, or in contact with the mandrel 200, the second side surface 16 is exposed and visible to a person skilled in the art of manufacturing the embolic device 10 (i.e., not in contact with the mandrel 200), not shown. Conversely, when the second side surface 16 of the elongated flat member 100 is disposed against, disposed on, or in contact with the mandrel 200, the first side surface 14 of the elongated flat member 100 is exposed and visible to a person skilled in the art of manufacturing the embolic device 10 (i.e., not in contact with the mandrel 200), as shown. Fig. 9 and Fig.10 shown.

[0048] In the three-dimensional unconstrained structure of the embolic device 10, the elongated flat member 100 presents a plurality of continuous loops 12, wherein the elongated flat member 100 is twisted at least partially around its longitudinal axis between each of the plurality of loops, such that regardless of changes in the direction and / or orientation of the elongated flat member 100, the first side surface 14 faces the outside of each loop 12 and the second side surface 16 faces the inside of each loop 12. The three-dimensional unconstrained structure of the embolic device 10 is provided by: arranging and winding the elongated flat member 100 on a mandrel (e.g., Fig. 9 and Fig.10 ) to form a plurality of continuous rings 12, the elongated flat member 100 is at least partially twisted about its longitudinal axis between each post of the mandrel forming each of the plurality of rings, so that regardless of changes in the direction and / or orientation of the elongated flat member 100, the first side surface 14 faces the outside of each post and / or ring, and the second side surface 16 faces the inside of each ring and is at least partially in contact with each post, respectively, such as Fig. 9 and Fig.10 shown.

[0049] In an embodiment of the disclosed invention, at least partial twisting of the elongated flat member 100 about its longitudinal axis between each ring and / or between each post is described in detail in Fig.11 The partial twist of the elongated flat member 100 around the longitudinal axis is about 120°, so that when the embolic device 10 is in a three-dimensional unconstrained structure, regardless of the change in the direction and / or orientation of the elongated flat member 100, the first side surface 14 of the elongated flat member 100 faces the outside of each ring 12, and the second side surface 16 of the elongated flat member 100 faces the inside of each ring, respectively. Figure 1 and Figure 2B It should be understood that in the three-dimensional unconstrained structure of the embolic device 10, regardless of the change in direction and / or orientation of the elongated flat member 100, the partial twist may include other suitable angles around the longitudinal axis of the elongated flat member 100, as long as one of the side surfaces of the elongated flat member 100 (e.g., the first side surface 14) faces the outside of each ring 12 and the opposite side surface of the elongated flat member 100 (e.g., the second side surface 16) faces the inside 11 of each ring 12, respectively.

[0050] In addition, the angle of twist between consecutive rings 12 can be expressed as a pitch at which a certain amount of twist angle exists per unit length. The twist pitch is preferably related to the diameter of adjacent rings 12, where the pitch is about 1 to 2 times 360° / πD, where D is the average curve diameter of adjacent rings 12. The twist pitch can vary between about 0.25 to about 4 times (360° / πD), and in some embodiments, the twist pitch can vary between about 0.75 times to about 2.5 times (360° / πD). In one embodiment, the twist of the elongated flat member 100 forming the three-dimensional unconstrained structure of the embolic device 10 typically occurs with a constant cross-section throughout the twist of the elongated flat member 100. Alternatively, the twist can occur in the case where the cross-section of the elongated flat member 100 varies throughout the twist.

[0051] For illustration purposes, Fig.12 An undesirable partial twisting (e.g., 60°) of the elongated flat member 100 about its longitudinal axis between each ring and / or between each post is depicted because such twisting will cause the first side surface 14 of the elongated flat member 100 to face outwardly and inwardly in alternating rings, and the second side surface 16 of the elongated flat member 100 will also face outwardly and inwardly in alternating rings.

[0052] The steps of arranging, placing, winding and / or twisting the elongated flat member 100 on the mandrel 200 according to the disclosed invention will be described in further detail below. After the elongated flat member 100 is arranged on the mandrel 200 to form the three-dimensional structure of the embolic device 10, the embolic device 10 is heat treated while the elongated flat member 100 is wound in alternating directions around respective posts extending outward from the mandrel, thereby forming a plurality of continuous loops 12. The three-dimensional unconstrained structure imparted to the embolic device 10 by heat treating the elongated flat member 100 as described above causes the device 10 to be biased to assume the three-dimensional unconstrained structure, such as the embolic device 10. Figure 1 and Figure 2B The mandrel 200 is constructed of a material having sufficient heat resistance to allow heat treatment of the embolic device 10. The mandrel 200 typically comprises a refractory material such as alumina or zirconia, or any other suitable heat resistant material.

[0053] Fig.13 A method 300 of manufacturing an embolic device 10 using the elongated flat member 100 and mandrel 200 described above is depicted in accordance with an embodiment of the disclosed invention.

[0054] In step 302, the proximal end 142 or the distal end 122 of the elongated flat member 100 is first placed on the mandrel 200 so that the first surface 14 or the second surface 16 contacts the mandrel 200. As a non-limiting example, the proximal end 142 of the elongated flat member 100 is arranged by the handle 210 disposed proximal to the extension posts 230, 232, 233, 234, 236 and 238 so that a portion of the second side surface 16 contacts the mandrel 200, as shown in FIG. Fig. 9 as shown in .

[0055] In step 304, the elongated flat member 100 is partially twisted about its longitudinal axis and further disposed around the first extension post to form a loop, with the first side facing outward (e.g., away from the post) and the second side facing inward (e.g., toward or partially contacting the post). For example, the elongated flat member 100 is extended so that it is partially twisted and wrapped around the first extension post 230 in a clockwise direction, with a portion of the second side surface 16 contacting the extension post 230, as shown in FIG. Fig. 9 as shown in .

[0056] In step 306, the elongated flat member 100 is partially twisted about its longitudinal axis and further disposed around the second elongated post to form a loop such that the first side faces outward (e.g., away from the post) and the second side faces inward (e.g., toward or partially in contact with the post). Fig. 9 As shown, the elongated flat member 100 is extended so that a portion is twisted and wrapped around the second extension column 232 in a counterclockwise direction, so that a portion of the second side surface 16 contacts the second extension column 232 .

[0057] In step 308, the elongated flat member 100 is partially twisted about its longitudinal axis and further disposed around the third elongated post to form a loop such that the first side faces outward (e.g., away from the post) and the second side faces inward (e.g., toward or partially in contact with the post). Fig. 9 As shown in FIG. 1 , the elongated flat member 100 is extended so that a portion is twisted and wrapped around the third extension column 233 in a clockwise direction, so that a portion of the second side surface 16 contacts the third extension column 233 .

[0058] In step 310, the elongated flat member 100 is partially twisted about its longitudinal axis and further disposed around a fourth elongated post to form a loop with the first side facing outward (e.g., away from the post) and the second side facing inward (e.g., toward or partially contacting the post). Fig. 9 As shown in , the elongated flat member 100 is extended so that a portion is twisted and wrapped around the fourth extension column 234 in a counterclockwise direction, so that a portion of the second side surface 16 contacts the fourth extension column 234.

[0059] In step 312, the elongated flat member 100 is partially twisted about its longitudinal axis and further disposed around the fifth extension post to form a loop, with the first side facing outward (e.g., away from the post) and the second side facing inward (e.g., toward or partially contacting the post). For example, the elongated flat member 100 is extended so that the portion is twisted and wrapped around the fifth extension post 236 in a clockwise direction, with a portion of the second side surface 16 contacting the extension post 236, as shown in FIG. Fig. 9 as shown in .

[0060] In step 314, the elongated flat member 100 is partially twisted about its longitudinal axis and further disposed around the sixth elongated post to form a loop such that the first side faces outward (e.g., away from the post) and the second side faces inward (e.g., toward or partially in contact with the post). Fig. 9 As shown in , the elongated flat member 100 is extended so that a portion is twisted and wrapped around the sixth extension column 238 in a counterclockwise direction, so that a portion of the second side surface 16 contacts the sixth extension column 238 .

[0061] In step 316, the elongated flat member 100 is heat treated to provide a three-dimensional unconstrained structure of the embolic device 10, such as Figure 1 and Figure 2B as shown in .

[0062] In optional step 318 prior to step 316, the elongated flat member 100 may be further partially twisted and disposed in alternating clockwise and counterclockwise directions around the stem and / or extension post such that the surface of the elongated flat member 100 at least partially contacts the extension post and stem.

[0063] It should be understood that in steps 302 to 316, the transfer of the slender flat part 100 from one column of the mandrel 200 to another column is discontinuous, in a wavy form, so that one of the side surfaces (e.g., 16) of the slender flat part 100 at least partially contacts the mandrel 200, while the opposite side surface (e.g., 14) is free, visible, or exposed (i.e., not contacting the mandrel 200).

[0064] The embolic device 10 resulting from the above-described manufacturing steps comprises a three-dimensional unconstrained structure having a plurality of continuous loops, wherein the elongated flat member 100 is at least partially twisted about its longitudinal axis between each of the plurality of loops so that the first side surface faces the outside of each loop and the second side surface faces the inside of each loop, respectively, regardless of changes in the direction and / or orientation of the elongated flat member, as shown in FIG. Figure 1 and Figure 2BThe side surface (e.g., surface 16) of the elongated flat member 100 disposed on the mandrel 200 during the manufacturing step faces the inner side 11 (e.g., the concave portion) of each ring 12, while the side surface (e.g., surface 14) of the elongated flat member 100 that does not contact the mandrel 200 during the manufacturing step faces the outer side (e.g., the convex portion) of each ring 12 of the embolic device 10 in the three-dimensional unconstrained structure, as shown in FIG. Figure 1 and Figure 2B shown.

[0065] The feature of the three-dimensional unconstrained structure of the embolic device 10 provides several important advantages, for example, for use as an embolic device intended for small diameter sites, such as neurovascular aneurysms. First, because the embolic device 10 includes a discontinuous transition region (e.g., a ring, a partial twist), the embolic device 10 can be forced into a highly compressed or contracted state with relatively small bends or stresses. This is in contrast to embolic devices that have sharp twists, bends, or turns and are insufficiently wrapped and cannot be tightly compressed due to their relatively rough transition regions. Similarly, the stress on the overlapping portions of the embolic device with sharp twists, bends, or turns, particularly during movement through a tortuous vascular path, may produce more contact points and friction between the embolic device and the delivery system, with undesirable effects (e.g., slower deployment of the embolic device, metal fatigue of the embolic device, etc.).

[0066] In addition, when the embolization device 10 is deployed into the aneurysm 20 through the delivery catheter 80 and deployed out of the delivery catheter 80 in the aneurysm, it presents a three-dimensional unconstrained structure ( Figure 2A-2B ), the elongated flat member 100 presents a plurality of continuous rings 12, wherein the elongated flat member 100 is at least partially twisted around its longitudinal axis between each of the plurality of rings 12, so that regardless of changes in the direction and / or orientation of the elongated flat member 100, the first side surface 14 faces the outside of each ring 12 toward the inner wall 22 of the aneurysm 20, while the second side surface 16 faces the inside 11 of each ring, so that the first side surface 14 of the device 10 engages and contacts the inner wall 22 of the aneurysm 20 without expanding the balloon or having any sharp turns or angles that may cause damage or rupture of the inner wall 22 of the aneurysm.

[0067] It should be appreciated that an embolic device 10 constructed in accordance with the disclosed invention may be deployed into a target site by methods known in the art.

[0068] Although specific embodiments have been shown and described herein, it will be understood by those skilled in the art that they are not intended to limit the present invention, and it will be apparent to those skilled in the art that various changes, substitutions and modifications (e.g., the size of each component, the combination of components) may be made without departing from the scope of the disclosed invention, which is limited only by the appended claims and their equivalents. Therefore, the specification and drawings should be considered in an illustrative rather than a restrictive sense. The various embodiments shown and described herein are intended to cover replacements, modifications and equivalents of the disclosed invention, which may all be included within the scope of the appended claims.

Claims

1. An embolization device, include: an elongated flat member having a longitudinal axis, a first side including a first side surface, and a second side including a second side surface, the first side and the second side being opposite to each other and the first side surface and the second side surface facing in opposite directions, The elongated flat member has an elongated constrained structure and a three-dimensional unconstrained structure for deployment to a targeted vascular site through a delivery catheter, the elongated flat member being composed of a metal selected from the group consisting of platinum group metals, rhenium, tungsten, gold, silver and tantalum, and alloys of any of the foregoing metals, wherein in said three-dimensional unconstrained structure, said elongated flat member presents a plurality of continuous loops, wherein said elongated flat member is at least partially twisted about said longitudinal axis of said elongated flat member between each of said plurality of loops such that, regardless of changes in direction and / or orientation of said elongated flat member, said first side surface faces the outside of each loop and said second side surface faces the inside of each loop, respectively, and A first ring of the plurality of rings defines a first plane, a second ring immediately adjacent to the first ring defines a second plane, and a third ring defines a third plane that is not coplanar with the first plane or the second plane.

2. The embolic device according to claim 1, wherein the platinum group metal is selected from the group consisting of platinum, rhodium and palladium, and wherein the alloy of the platinum group metal is selected from the group consisting of alloys of platinum, alloys of rhodium and alloys of palladium.

3. The embolic device of claim 1, wherein the elongated flat member comprises a braided mesh formed entirely of gold-platinum alloy wires or gold-platinum alloy wires.

4. The occluding device of claim 1, wherein the elongated flat member comprises a braid formed of one or more braided members.

5. The occlusive device of claim 4, wherein the one or more braided components are wires or threads.

6. The occluding device according to claim 4 or 5, wherein the elongated flat member comprises a flattened tubular braid.

7. The occluding device according to claim 4 or 5, wherein the elongated flat member comprises a single layer of flat ribbon-like braid.

8. The embolic device of claim 1, wherein the three-dimensional unconstrained structure is imparted to the elongated flat member by heat treating the elongated flat member while wrapping the elongated flat member in alternating directions around respective posts extending outwardly from a core shaft thereby forming a plurality of continuous loops.

9. The occluding device of claim 1, wherein the direction of the curve of the first ring is opposite to the direction of the curve of the adjacent ring when viewed from the outside toward the centroid of the three-dimensional unconstrained structure.

10. The occluding device of claim 1, wherein the plurality of continuous rings comprises at least five continuous rings.

11. The occluding device of claim 1, wherein in the three-dimensional unconstrained structure, the elongated flat member comprises a torsional pitch.

12. The occluding device of claim 11, wherein the torsional pitch is 1.5 times 360° / πD, where D is the average curvilinear diameter of adjacent loops.

13. The occluding device of claim 11, wherein the torsional pitch varies from 0.25 times (360° / πD) to 4 times (360° / πD), where D is the average curvilinear diameter of adjacent loops.

14. The occluding device of claim 11, wherein the torsional pitch varies from 0.75 times (360° / πD) to 2.5 times (360° / πD), where D is the average curvilinear diameter of adjacent loops.

15. The occluding device of claim 1, wherein in the three-dimensional unconstrained structure, the elongated flat member comprises a constant cross-section throughout the torsion.

16. The occluding device of claim 1, wherein in the three-dimensional unconstrained structure, the elongated flat member comprises a variable cross-section throughout its torsion.